GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (NAS:VIVO) » Definitions » Cyclically Adjusted PB Ratio

Meridian Bioscience (Meridian Bioscience) Cyclically Adjusted PB Ratio : 6.02 (As of May. 24, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience Cyclically Adjusted PB Ratio?

As of today (2024-05-24), Meridian Bioscience's current share price is $33.97. Meridian Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 was $5.64. Meridian Bioscience's Cyclically Adjusted PB Ratio for today is 6.02.

The historical rank and industry rank for Meridian Bioscience's Cyclically Adjusted PB Ratio or its related term are showing as below:

VIVO's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.98
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Meridian Bioscience's adjusted book value per share data for the three months ended in Sep. 2022 was $8.414. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.64 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Meridian Bioscience Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Meridian Bioscience's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Cyclically Adjusted PB Ratio Chart

Meridian Bioscience Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.72 2.31 3.97 3.98 5.59

Meridian Bioscience Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 4.07 4.92 5.50 5.59

Competitive Comparison of Meridian Bioscience's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Meridian Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meridian Bioscience's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's Cyclically Adjusted PB Ratio falls into.



Meridian Bioscience Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Meridian Bioscience's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=33.97/5.64
=6.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meridian Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, Meridian Bioscience's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:

Adj_Book=Book Value per Share/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=8.414/125.2265*125.2265
=8.414

Current CPI (Sep. 2022) = 125.2265.

Meridian Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201212 3.339 96.871 4.316
201303 3.578 98.209 4.562
201306 3.648 98.518 4.637
201309 3.734 98.790 4.733
201312 3.788 98.326 4.824
201403 3.858 99.695 4.846
201406 3.893 100.560 4.848
201409 3.869 100.428 4.824
201412 3.857 99.070 4.875
201503 3.862 99.621 4.855
201506 3.930 100.684 4.888
201509 3.965 100.392 4.946
201512 4.009 99.792 5.031
201603 4.037 100.470 5.032
201606 4.013 101.688 4.942
201609 3.954 101.861 4.861
201612 3.927 101.863 4.828
201703 4.048 102.862 4.928
201706 3.970 103.349 4.810
201709 4.018 104.136 4.832
201712 4.086 104.011 4.919
201803 4.117 105.290 4.897
201806 4.134 106.317 4.869
201809 4.137 106.507 4.864
201812 4.204 105.998 4.967
201903 4.272 107.251 4.988
201906 4.419 108.070 5.121
201909 4.471 108.329 5.168
201912 4.607 108.420 5.321
202003 4.775 108.902 5.491
202006 5.447 108.767 6.271
202009 5.750 109.815 6.557
202012 6.467 109.897 7.369
202103 7.142 111.754 8.003
202106 7.431 114.631 8.118
202109 7.571 115.734 8.192
202112 7.933 117.630 8.445
202203 8.598 121.301 8.876
202206 8.361 125.017 8.375
202209 8.414 125.227 8.414

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Meridian Bioscience  (NAS:VIVO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Meridian Bioscience Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Meridian Bioscience (Meridian Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
3471 River Hills Drive, Cincinnati, OH, USA, 45244
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Executives
Julie Diana Smith officer: Sr VP, Controller, PAO 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
John P. Kenny director, officer: Chief Executive Officer 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Andrew S. Kitzmiller officer: EVP & CFO ONE BATESVILLE BLVD., BATESVILLE IN 47006
Bryan T Baldasare officer: Interim CFO & Chief Acctg Off 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Rice John Mccune Jr. director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Bihl Anthony P Iii director 807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Tony Serafini-lamanna officer: Executive VP-Diagnostics 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Felicia Williams director C/O MACY'S, INC., 151 WEST 34TH STREET, NEW YORK NY 10001
John Mcilwraith director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
David Phillips director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
James M. Anderson director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Dwight E Ellingwood director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lawrence Baldini officer: Exec VP, Operations & IS 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Eric S. Rasmussen officer: EVP, Bus. Development/Strategy 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Lourdes Weltzien officer: EVP, Life Science 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244

Meridian Bioscience (Meridian Bioscience) Headlines

From GuruFocus

DoubleVerify Holdings to Join S&P SmallCap 600

By PRNewswire PRNewswire 01-25-2023